Jump to navigation
Having costly procedures subsidised will allow equitable access for all patients.
But the data could be skewed, authors caution.
The NSW Health Minister is under serious pressure.
The link remains unclear and stronger trials are needed.
The relationship isn't as simple as it might look.
Many say they'd rather die than live with a debilitating illness or disability.
A new study is said to avoid the methodological flaws of previous research.
GPs are being reminded to check for renal impairment when prescribing type 2 diabetes medication.
Other cases might emerge, health authorities say.
Most women can manage their symptoms without drugs.
It's particularly effective in people with hyperuricaemia.
Early detection and treatment is crucial, Australian doctors say.
The message is that different pills affect patients to different degrees.
Two experts present their opposing cases.
Feelings of being 'in control' can be as important as practical issues such as cost.
But it might still be worth considering in certain patients.
There's a dose-response relationship, but patients should hit this mark to reduce pain.
Looking beyond the usual suspects.
When it comes to describing patients who suffer from disease, our choice of appropriate words continues to evolve...
Sulfonylureas remain the usual initial second-line option.
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.